60 DEGREES PHARMACEUTICALS, INC. 8-KCurrent Reports (8-K / ad hoc)

Market for Equity / Stockholders

Item 5.07 Submission of Matters to a Vote of Security Holders. On August 5, 2026, 60 Degrees Pharmaceuticals, Inc., a Delaware corporation (the “Company”), held its virtual 2026 Annual Stockholders Meeting (the “Meeting”). As of the close of business on July 2, 2026, the record date for the determination of stockholders entitled to vote at the Meeting, there were 2,659,288 shares of the Company’s common stock, par value $0.0001 per share, issued and outstanding, with each share entitled to one vote on each proposal at the Meeting. At the Meeting, the combined holders of 1,107,592 shares of the voting stock entitled to notice of and to vote at the Meeting were represented in person or by proxy, representing approximately 41.6% of the outstanding voting shares, and thereby a quorum pursuant to the Delaware General Corporation Law and the amended and restated bylaws of the Company was present for the transaction of business at the Meeting. The final results for each of the matters considered at the Meeting were as follows: 1. To elect five (5) directors to serve until the 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified. Geo ff rey Dow Votes For Votes Withheld Broker Non-Votes 147,223 25,031 935,338 Eric Francois Votes For Votes Withheld Broker Non-Votes 141,202 31,052 935,338 Cheryl Xu Votes For Votes Withheld Broker Non-Votes 142,103 30,151 935,338 Stephen Toovey Votes For Votes Withheld Broker Non-Votes 140,160 32,094 935,338 Paul Field Votes For Votes Withheld Broker Non-Votes 141,336 30,918 935,338 Field: Page; Sequence: 2; Options: NewSection; Value: 1 Field: Sequence; Type: Arabic; Name: PageNo 1 Field: /Sequence Field: /Page The affirmative vote of the holders of a majority of the shares represented at the Meeting and entitled to vote was required for approval. The proposal was approved. 2. To approve an amendment to the 60 Degrees Pharmaceuticals, Inc. 2022 Equity Incentive Plan to increase the number of shares of common stock available for issuance by 800,000 shares. Votes For Votes Against Abstentions 126,984 44,464 806 The affirmative vote of the holders of a majority of the shares represented at the Meeting and entitled to vote was required for approval. The proposal was approved. 3. Approval of an amendment to the certificate of incorporation, as corrected, of the Company, to effect a reverse